Use access key #2 to skip to page content.
$5.81 -0.36 (-5.83%)
1/9/2009 4:00 PM

Enzon Pharmaceuticals, Inc. (ENZN)

CAPS Rating:
****

A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.

View All Commentary (ENZN)

Recs

0

Avatar WonderWolf (74.90) Submitted: 5/20/08 11:48 PM : Outperform Start Price: $8.88 ENZN Score: 2.60

Working on 2 cancer drugs and will be the big winner!!

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links